drugset / Trial / NCT07423299
A First-in-Human Single and Multiple Ascending Dose Study of MT-251
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Doses of MT-251 in Healthy Participants
Timeline
- Start
- 2026-01-23
- Primary completion
- 2027-03-08
- Completion
- 2027-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MT-251 | Unknown | — | Intravenous |
Indications
No indication recorded.